India declines proposal to test Sputnik-V Covid vaccine in large study
India's move comes as a setback for Russia's plan to roll-out the vaccine even before full trials show how well it works, while pushing back its efforts to win approval for the vaccine in the country that leads the world on average number of new infections. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 8, 2020 Category: Pharmaceuticals Source Type: news

After tablets, Hetero working on antiviral medicine Favipiravir injections
If successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only in oral form, and emerge as one of the few global firms to record such a feat. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 8, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila launches new product for COPD patients in India
Drug firm Zydus Cadila on Thursday said it is launching pressurized metered dose inhaler for patients suffering from Chronic Obstructive Pulmonary Disease (COPD) in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 8, 2020 Category: Pharmaceuticals Source Type: news

Centre to map out cold chain storage facilities in preparation for COVID-19 vaccine delivery
A national expert group is talking to public and private sector entities in the pharmaceutical sector, food processing industry and agro businesses as well as food delivery start-ups such as Swiggy and Zomato to identify cold storages or fridges at the taluka level that can stock and distribute the vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 8, 2020 Category: Pharmaceuticals Source Type: news

Majority of generic drug ingredients produced in India & China: European Study
European governments were rattled at the start of the coronavirus outbreak when India, one of the biggest producers of drug ingredients, banned exports of certain products relevant to the pandemic, prompting concerns about disruptions to supply chains and a shortage of medicines. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 6, 2020 Category: Pharmaceuticals Source Type: news

Glenmark Pharma gets USFDA nod to market drug for relapsing multiple sclerosis
Drug major Glenmark Pharma said it has received final approval from the US health regulator for Dimethyl Fumarate delayed-release capsules, used for the treatment of relapsing forms of multiple sclerosis in adults. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 6, 2020 Category: Pharmaceuticals Source Type: news

COVID-19 recoveries exceeded active cases by over 48 lakh: Health Ministry
The number of people recovered from COVID-19 has exceeded those with active infection by more than 48 lakh as the recovery rate surpassed 85 per cent on Wednesday, the Union Health Ministry said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 6, 2020 Category: Pharmaceuticals Source Type: news

Dr Reddy's Laboratories to submit a revised protocol for conducting clinical trials of Russian COVID-19 vaccine
In a meeting held on Monday, Subject Expert Committee (SEC) on COVID-19 at the CDSCO, deliberated on the application and asked the firm to resubmit a revised protocol as it was not satisfied with the data of Phase II trials submitted by the company, sources told ET. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 5, 2020 Category: Pharmaceuticals Source Type: news

EU reviewing Pfizer-BioNTech COVID-19 vaccine in real time
Pfizer and BioNTech said in a joint statement the start of the review is based on data from laboratory and animal testing, as well as early testing on humans, while continuing talks to submit data as it emerged. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 5, 2020 Category: Pharmaceuticals Source Type: news

GSK to widen COVID-19 antibody treatment trial after safety clearance
The long-acting single injection will be tested on recently diagnosed high-risk cases for its ability to prevent hospitalisation, typically a life threatening disease stage. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 5, 2020 Category: Pharmaceuticals Source Type: news

DCGI nod to Phase-1 human trials of 'antisera' with potential to treat COVID-19
Antisera are blood serum high in antibodies against specific antigens and are injected in humans to help kickstart the immune system to fight specific infections. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 5, 2020 Category: Pharmaceuticals Source Type: news

As production of N-95 masks grows, govt plans exports
India now produces 400,000-500,000 N-95 masks daily and has potential to increase production significantly. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 5, 2020 Category: Pharmaceuticals Source Type: news

Bharat Biotech to use ViroVax's adjuvant in Covid vaccine
Bharat Biotech has teamed up with ViroVax to use the US scientific research firm ’s adjuvant for boosting the immune response and providing long-lasting immunity to its novel vaccine candidate Covaxin, which has entered phase-2 human trials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 5, 2020 Category: Pharmaceuticals Source Type: news

With Aarogya Setu we can identify a place before it turns into a hotspot: Abhishek Singh
"Contact tracing has emerged as one of the key components of Covid-19 pandemic management," Abhishek Singh, CEO of MyGov and Digital India Corporation, a government organisation leading the health ministry ’s contact tracing efforts. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 5, 2020 Category: Pharmaceuticals Source Type: news

Dr Reddy's joins hands with SBTi, aims to cut greenhouse gas emissions by 55 per cent by 2030
As of 2019-20 fiscal, Dr Reddy's said it reduced its Scope 1 emissions by 8.6 per cent and Scope 2 emissions by 20.7 per cent over the baseline of 2017-18 fiscal. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 4, 2020 Category: Pharmaceuticals Source Type: news

Large pharma companies back appeal for TRIPS waiver for Covid-19 cure
“We endorse the Indian government’s stand asking for a waiver of the TRIPS provisions to deal with the Covid-19 crisis. This is the time for solidarity and global cooperation,” Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance, told ET on Sunday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 4, 2020 Category: Pharmaceuticals Source Type: news

Telangana opposes move to allocate pharma parks project based on costs
The Union government, which proposes to allocate Rs 1,000 crore for each of the three bulk drug parks that will be chosen based on competitive land prices, power tariffs, incentives as well as quick clearances by states, has fixed October 15 as the deadline for states to submit their requests with details of costs and incentives. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 4, 2020 Category: Pharmaceuticals Source Type: news

States, Union Territories asked to get storage facilities ready for Covid-19 vaccines
The government expert group on vaccines, which looks into the procurement of Covid-19 vaccines from India and abroad and the guiding principles for prioritisation of groups for vaccination, has proposed setting up a digital platform to track procurement and record administration. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 4, 2020 Category: Pharmaceuticals Source Type: news

Researchers develop new, inexpensive COVID-19 test that doesn't use scarce reagents
The method, described in the journal PLOS Biology, omits the step in the widely used reverse transcription polymerase chain reaction (RT-PCR) test where the scarce reagents are needed, but has an accuracy of 92 per cent, missing only the lowest viral loads. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 3, 2020 Category: Pharmaceuticals Source Type: news

India and S.Africa ask WTO to waive rules to aid COVID-19 drug production
In their letter dated Oct. 2 the two countries called on the global trade body to waive parts of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which governs patents, trademarks, copyright and other intellectual property rules globally. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 3, 2020 Category: Pharmaceuticals Source Type: news

India and South Africa demand waiver of certain provisions of Intellectual Property for Covid-19 therapeutics
This statement comes at a time when the race for Covid-19 vaccine is heating up across the world. Though most vaccine makers have received government funding to develop Covid-19 vaccines companies have remained firm that they won ’t be giving up patents or the IP of these vaccines. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 2, 2020 Category: Pharmaceuticals Source Type: news

Oxford University coronavirus vaccine could be rolled out within six months: Report
The vaccine candidate under trial by University of Oxford scientists in collaboration with pharmaceutical giant AstraZeneca is the furthest in the process of trials and, according to a report in ‘The Times', it could be given the required clearances by Christmas in December. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 2, 2020 Category: Pharmaceuticals Source Type: news

Dr Reddy's seeks DCGI nod to conduct phase-3 clinical trial of Russian COVID-19 vaccine
The Indian pharma giant has collaborated with The Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V as well as its distribution. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 1, 2020 Category: Pharmaceuticals Source Type: news

Hindustan Syringes and Medical Devices ships over 56m syringes to Covax facility
The Covax facility, which seeks to pool in resources to accelerate the development of the promising vaccine candidates for Covid-19 that will be made accessible to all the participating countries, has ordered 140 million pieces to be supplied between August and December. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 1, 2020 Category: Pharmaceuticals Source Type: news

ICMR, Biological E develop purified equine antiserum
The therapy works like plasma therapy. However, the blood plasma is obtained from animals — from horses, in this case — that have recovered from a viral infection and found to have antibodies against the virus in their system. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 1, 2020 Category: Pharmaceuticals Source Type: news

How Russia shortened the Covid vaccine race in rush to declare victory
The vaccine will be ready for wide distribution late this year or early next, officials say. That's roughly the same schedule as shots from rivals in the U.S., U.K. and China. Initial results from final-stage studies won ’t be ready until November, with full data expected next year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 1, 2020 Category: Pharmaceuticals Source Type: news

COVID-19 vaccine rollout unlikely before fall 2021, experts say
An effective vaccine is not likely to be available for the general public before the fall of 2021, according to experts working in the field of vaccine development. Researchers at McGill University in Canada carried out a survey of 28 experts working in vaccinology in late June 2020. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 1, 2020 Category: Pharmaceuticals Source Type: news

Syngene International joins global consortium of 19 healthcare organisations on COVID-19 testing
A diverse group of companies with synergistic areas of expertise, including precision medicine, diagnostics, occupational health, pharmaceuticals and clinical testing laboratories, the consortium will help provide clarity and potential solutions to COVID-19 testing challenges, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 30, 2020 Category: Pharmaceuticals Source Type: news

E-pharmacies urge government to notify e-pharmacy rules
"It is our sincere request that the government notify the final e-pharmacy rules," the association added. Draft e-Pharmacy Rules are in addition to, and not in substitution of, the existing legal framework of the IT act and DC (Drugs and Cosmetics) Act and Rules, which the existing e-pharmacies are fully compliant with, the letter said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 30, 2020 Category: Pharmaceuticals Source Type: news

COVID-19 crisis highlighted need for more investment in health sector: Ayushman Bharat CEO
“The (COVID-19) crisis showed the fault lines in the health sector. India is investing too little in health and it is one of the lowest in the world. This crisis has shown that we need to do much more and we need to invest more in the primary, secondary and critical care,” Indu Bhushan was quote d as saying in the statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 30, 2020 Category: Pharmaceuticals Source Type: news

Best time to invest in pharma, medical device sector: DV Sadananda Gowda
The Indian pharma sector, currently valued at USD 40 billion, has the potential to become a global pharmacy hub in the coming years, the Chemicals and Fertilisers Minister said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 30, 2020 Category: Pharmaceuticals Source Type: news

Trump-touted hydroxychloroquine shows no benefit in COVID-19 prevention: Study
The study largely confirms results from a clinical trial in June that showed hydroxychloroquine was ineffective in preventing infection among people exposed to the new coronavirus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 29, 2020 Category: Pharmaceuticals Source Type: news

Government dismisses Adar Poonawalla ’s 80,000 crore estimate for vaccine distribution
The comment came in the wake of a tweet by Serum Institute of India chief executive Adar Poonawalla last week asking the government whether it will have Rs 80,000 crore available over next one year to cater to the country ’s requirement of Covid-19 vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 29, 2020 Category: Pharmaceuticals Source Type: news

Pharma company Panacea Biotec gets warning letter from USFDA for Baddi facility
The company will actively engage with the agency and take all necessary steps required to address the United States Food and Drug Administration (USFDA) concerns, Panacea Biotec said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 29, 2020 Category: Pharmaceuticals Source Type: news

Pharmaceutical sector added highest number of Indians in the rich list: Report
Mukesh Ambani, Chairman of India ’s most valued firm Reliance Industries, continues to top the IIFL Wealth Hurun India Rich List 2020 for the ninth consecutive year, with a total wealth of INR 6,58,400 crore. His total wealth has surged by 73% in the last 12 months. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 28, 2020 Category: Pharmaceuticals Source Type: news

Favipiravir fastest molecule to cross Rs 100 cr
Favipiravir, a drug used in the treatment of Covid-19 patients with mild symptoms, became the largest-selling medicine in India in September, with locally made versions notching up sales of Rs 140 crore. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 28, 2020 Category: Pharmaceuticals Source Type: news

ET Analysis: Covid-impacted Indian healthcare is hitting high & low notes simultaneously
The pandemic has yet again brought home the truth to investors that healthcare in India cannot be run like any other business. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 28, 2020 Category: Pharmaceuticals Source Type: news

India initiates probe against alleged dumping of pharma raw material by Chinese firms
Nectar Life Sciences and Sterile India have filed an application before the Commerce Ministry''s investigation arm Directorate General of Trade Remedies (DGTR) seeking initiation of the probe. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 27, 2020 Category: Pharmaceuticals Source Type: news

Health ministry launches web portal for updates on Covid-19 vaccine development
The ''vaccine web portal'' and the ''National Clinical Registry for COVID-19'' have been developed by the Indian Council of Medical Research (ICMR) and was launched by Union Health Minister Harsh Vardhan, according to a health ministry statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 27, 2020 Category: Pharmaceuticals Source Type: news

Sun Pharma bullish on specialty biz, looks to expand the segment to new geographies
Sharing information with shareholders, Sun Pharmaceutical Industries Managing Director Dilip Shanghvi said the company's strategy of developing the specialty business as an additional growth engine has started delivering results, with a gradual ramp up in specialty revenues. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 26, 2020 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches generic drug to treat multiple sclerosis in US
The company's product is a therapeutic equivalent generic version of Biogen's Tecfidera delayed-release capsules, the Hyderabad-based drug firm said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 25, 2020 Category: Pharmaceuticals Source Type: news

Will govt have Rs 80,000 cr for distribution of vaccine, asks Serum Institute CEO
This is the next "challenge" we need to tackle, he said, also tagging the prime minister's office. "I ask this question because we need to plan and guide, vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution," Poonawalla added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 25, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets US health regulator nod for multiple sclerosis treatment drug
Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed release capsules, (Tecfidera) in the strengths of 120 mg and 240 mg, Zydus Cadila, part of Cadila Healthcare group, said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 24, 2020 Category: Pharmaceuticals Source Type: news

Hetero launches pack of generic COVID-19 drug favipiravir at Rs 2,640
"The launch of 'Favivir 800/200' is aimed at enhancing patients' adherence to treatment regimen by reducing the number of pills they are required to consume per day," Hetero said. The product will be made available at all retail medical outlets and hospital pharmacies across the country and sold only on prescription, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 24, 2020 Category: Pharmaceuticals Source Type: news

Supply delays, rise in Covid cases lead to Remdesivir shortage
In Maharashtra, which has the highest number of Covid-19 cases in the country, the state health minister said due to batch failures of certain pharma companies, the drug was in short supply. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 24, 2020 Category: Pharmaceuticals Source Type: news

Export boost to help pharma sector come out 'unscathed' from COVID-19 pandemic
CRISIL said, "In 2020-21, growth in exports at 11-12 per cent, as against 10 per cent last fiscal, will outpace growth in domestic formulations expected at 5-6 per cent from 10 per cent in 2019-20." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 23, 2020 Category: Pharmaceuticals Source Type: news

The world should get a COVID-19 vaccine by early 2021, says Microsoft founder Bill Gates
"I am optimistic that by early next year, of the six western constructs, probably three or four will have shown safety and efficacy, and four of those can be made at large scale and low cost, including AstraZeneca, Johnson& Johnson, Novavax and Sanofi," the co-chair of the Bill and Melinda Gates foundation told the ET Global Business Summit. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 23, 2020 Category: Pharmaceuticals Source Type: news

Centre does a U-turn, says no plans to make pharmaceutical marketing code mandatory
On September 18, when chemicals minister DV Sadananda Gowda was asked if the government had decided to make the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) mandatory, he said no. This is a u-turn from the government reply in the Lok Sabha on May 15, 2016 when it said: “...code was reviewed and it was now decided to make it statutory. Once the code is made statutory it is expected that the unethical practices could be controlled more effectively.” (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 23, 2020 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets tentative USFDA nod to market anti-cancer drug
Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer drug Palbociclib Capsules. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 23, 2020 Category: Pharmaceuticals Source Type: news

Panacea Biotec completes Phase I/II study of DengiAlI vaccine
According to the World Health Organization, dengue represents one of the 10 biggest global health threats and it is critical to have access to a safe and effective vaccine candidate that can reduce the devastating impact of dengue fever in endemic regions, Panacea Biotec said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 23, 2020 Category: Pharmaceuticals Source Type: news